Cargando…
Summary of the Comparative Effectiveness Review on Off-Label Use of Atypical Antipsychotics
BACKGROUND: Conventional and atypical antipsychotic medications are approved by the FDA for treatment of schizophrenia and bipolar disorder. Over many decades, the widespread use of conventional antipsychotics produced various side effects requiring additional medications, such as the atypical antip...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438344/ https://www.ncbi.nlm.nih.gov/pubmed/22784311 http://dx.doi.org/10.18553/jmcp.2012.18.S5-B.1 |